Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$245,883
New position
Shares Held
205
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#4,298
of 4,605 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Orographic Financial Advisors, LLC holds $9,306,436 across 8 Drug Manufacturers - General names. LLY ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
51,149 | $2,947,205 | |
| 2 | JNJ |
Johnson & Johnson
|
9,761 | $2,479,001 | |
| 3 | PFE |
Pfizer Inc
|
79,941 | $1,924,979 | |
| 4 | ABBV |
AbbVie Inc.
|
4,211 | $1,059,656 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,657 | $469,924 | |
| 6 | LLY |
ELI LILLY & Co
This page
|
205 | $245,883 | |
| 7 | OGN |
Organon & Co.
|
13,234 | $179,188 | |
| 8 | AMGN |
Amgen Inc
|
1,442 | $600 |
All Filings in LLY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $245,883 | 205 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||